UK pharma major AstraZeneca’s Calquence (acalabrutinib) in combination with venetoclax has been approved in the USA as the ...

Atlanta, USA-based clinical-stage pharmaceutical company Altesa BioSciences has announced a $75 million oversubscribed Series ...

Danish allergy immunotherapy specialist ALK Abello has announced that Henriette Mersebach will step down imminently as executive vice president, research and development, and as a member of the board.

Russian drugmakers continue active marketing and sales of their generics prior to expiration of patents for original drugs, reports he Pharma Letter's local correspondent.

Danish allergy immunotherapy specialist ALK Abello today revealed that its full-year results came in at the top end of the latest outlook, supported by solid performance in the fourth quarter and ...

Swiss pharma giant Novartis today announced that Pluvicto (plutetium-177 vipivotide tetraxetan) has received MHRA approval ...

US drugmaker Eli Lilly has announced positive topline results from the landmark TOGETHER-PsO open-label Phase IIIb trial ...

The Russian government has begun a procedure for the creation of the list of vital and essential drugs for 2026. It is ...

US pharma giant Merck & Co and hospital system Mayo Clinic have announced a research and development agreement to apply artificial intelligence (AI), advanced analytics and multimodal clinical data, ...

US mRNA specialist Moderna today announced that, in response to a prior Refusal-to-File (RTF) letter, the company engaged ...

Italian pharma major Recordati has reported 2025 revenues of 2.62 billion euros ($3.1 billion), which was in line with ...

Ocular Therapeutix has announced positive topline results from the SOL-1 Phase III superiority trial of Axpaxli—also known as ...